BUZZ-SINTX rises after first use of FDA-cleared implant, names new president

Reuters03-23

BUZZ-SINTX rises after first use of FDA-cleared implant, names new president

** Shares of biomaterials maker SINTX Technologies SINT.O rise 7% to $2.75

** Co says a surgeon performed the first human surgery using its FDA-cleared SINAPTIC Foot & Ankle Osteotomy Wedge System, marking SINTX's entry into the foot and ankle reconstruction market

** The system is used to correct bone alignment problems in the foot and ankle, a common issue linked to joint damage and deformities, co says

** Says it also named Ryan Elmore as president to lead commercialization and revenue growth efforts

** Co says it is preparing for commercial rollout of the SINAPTIC wedge system and targeting revenue growth in 2026 after streamlining operations and raising about $10 million over the past year

** Says it is expanding manufacturing, including AI‑assisted 3D printing, and exploring new uses of its silicon nitride beyond implants

** Share up ~10% in 2025

(Reporting by Sahil Pandey in Bengaluru)

((Sahil.Pandey@thomsonreuters.com))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2621701928?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-23 21:59","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2621701928","market":"nz","top_or_hot":-1,"title":"BUZZ-SINTX rises after first use of FDA-cleared implant, names new president","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-SINTX rises after first use of FDA-cleared implant, names new president</title></head><body><p>** Shares of biomaterials maker SINTX Technologies <span>SINT.O</span> rise 7% to $2.75 </p><p>** Co says a surgeon performed the first human surgery using its FDA-cleared SINAPTIC Foot &amp; Ankle Osteotomy Wedge System, marking SINTX's entry into the foot and ankle reconstruction market</p><p>** The system is used to correct bone alignment problems in the foot and ankle, a common issue linked to joint damage and deformities, co says</p><p>** Says it also named Ryan Elmore as president to lead commercialization and revenue growth efforts</p><p>** Co says it is preparing for commercial rollout of the SINAPTIC wedge system and targeting revenue growth in 2026 after streamlining operations and raising about $10 million over the past year</p><p>** Says it is expanding manufacturing, including AI‑assisted 3D printing, and exploring new uses of its silicon nitride beyond implants</p><p>** Share up ~10% in 2025</p><p> (Reporting by Sahil Pandey in Bengaluru)</p><p> ((Sahil.Pandey@thomsonreuters.com))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-SINTX rises after first use of FDA-cleared implant, names new president</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-SINTX rises after first use of FDA-cleared implant, names new president\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-03-23 21:59</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-SINTX rises after first use of FDA-cleared implant, names new president</title></head><body><p>** Shares of biomaterials maker SINTX Technologies <span>SINT.O</span> rise 7% to $2.75 </p><p>** Co says a surgeon performed the first human surgery using its FDA-cleared SINAPTIC Foot &amp; Ankle Osteotomy Wedge System, marking SINTX's entry into the foot and ankle reconstruction market</p><p>** The system is used to correct bone alignment problems in the foot and ankle, a common issue linked to joint damage and deformities, co says</p><p>** Says it also named Ryan Elmore as president to lead commercialization and revenue growth efforts</p><p>** Co says it is preparing for commercial rollout of the SINAPTIC wedge system and targeting revenue growth in 2026 after streamlining operations and raising about $10 million over the past year</p><p>** Says it is expanding manufacturing, including AI‑assisted 3D printing, and exploring new uses of its silicon nitride beyond implants</p><p>** Share up ~10% in 2025</p><p> (Reporting by Sahil Pandey in Bengaluru)</p><p> ((Sahil.Pandey@thomsonreuters.com))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"医疗保健设备","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nL4N40B17Z:1","article_id":"2621701928","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2621701928","pubTimestamp":1774274367,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-SINTX rises after first use of FDA-cleared implant, names new president** Shares of biomaterials maker SINTX Technologies SINT.O rise 7% to $2.75 ** Co says a surgeon performed the first human surgery using its FDA-cleared SINAPTIC Foot & Ankle Osteotomy Wedge System, marking SINTX's entry into the foot and ankle reconstruction market** The system is used to correct bone alignment problems in the foot and ankle, a common issue linked to joint damage and deformities, co says** Says it also named Ryan Elmore as president to lead commercialization and revenue growth efforts** Co says it is preparing for commercial rollout of the SINAPTIC wedge system and targeting revenue growth in 2026 after streamlining operations and raising about $10 million over the past year** Says it is expanding manufacturing, including AIassisted 3D printing, and exploring new uses of its silicon nitride beyond implants** Share up ~10% in 2025  ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","SINT":"SINTX Technologies Inc"},"translate_title":"BUZZ-SINTX在首次使用FDA批准的植入物后股价上涨，任命新总裁","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SINT":0.9},"content_text":"BUZZ-SINTX rises after first use of FDA-cleared implant, names new president** Shares of biomaterials maker SINTX Technologies SINT.O rise 7% to $2.75 ** Co says a surgeon performed the first human surgery using its FDA-cleared SINAPTIC Foot & Ankle Osteotomy Wedge System, marking SINTX's entry into the foot and ankle reconstruction market** The system is used to correct bone alignment problems in the foot and ankle, a common issue linked to joint damage and deformities, co says** Says it also named Ryan Elmore as president to lead commercialization and revenue growth efforts** Co says it is preparing for commercial rollout of the SINAPTIC wedge system and targeting revenue growth in 2026 after streamlining operations and raising about $10 million over the past year** Says it is expanding manufacturing, including AI‑assisted 3D printing, and exploring new uses of its silicon nitride beyond implants** Share up ~10% in 2025 (Reporting by Sahil Pandey in Bengaluru) ((Sahil.Pandey@thomsonreuters.com))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"executive","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2621701928","isCrawlerRequest":true}